Advertisement
Home 2025

Archives

ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer

0

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy

One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years

0

Five-fraction schedule over one week as safe and effective as standard three-week schedule in adjuvant breast radiotherapy

Severe Exacerbations Down With As-Needed Albuterol-Budesonide for Mild Asthma

0

Severe exacerbation occurred in fewer patients receiving albuterol-budesonide versus those receiving albuterol only

Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy

0

Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours

Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss

0

Strong outcomes seen in terms of weight loss, with lower doses of semaglutide used

Trend Toward Survival Benefit Seen for REM-Inhibition in ALS

0

REM inhibition via receipt of antidepressant medications associated with trend toward survival benefit

Pulmonary Embolism More Common in Children Than Previously Thought

0

Rates similar to adults presenting to the emergency department with symptoms

Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis

0

Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity

Adding Team Therapist Reduces Burnout for Critical Care Nurses

0

Adding team therapist linked to improvement in job satisfaction, burnout, resilience

Wearable Sensor Can Monitor Sleep Apnea Treatment Response

0

A wearable pulse oximeter and connected software platform shows patient acceptability in ongoing trials